Pharmafile Logo
Pharmafocus logo
Advanced Search

Goldacre

Showing 15 posts of 39 posts found.

EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

News
data report

Sharing trial data should be ‘expected norm’ says US think-tank

January 15, 2015
Medical Communications, Research and Development, Sales and Marketing FDA, Goldacre, Institute of Medicine, clinical trials, transparency

Clinical trial data is in the public interest and should be shared no less than 30 days following regulatory approval …

News
EMA image

EMA responds to redaction concerns

November 14, 2014
Sales and Marketing AbbVie, EMA, Goldacre, Humira, Rasi, adalimumab, redactions, transparency

The EMA has published a response to European Ombudsman Emily O’Reilly’s questions about some of its trial data redactions. O’Reilly’s …

News
Jane Griffiths, company group chairman for Janssen EMEA and chairwoman of the EF

Janssen: why transparency is essential to the health of our industry

August 29, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

News
Trials image

Publish all clinical trials, say pharma doctors

August 29, 2014
Research and Development, Sales and Marketing Goldacre, all trials, data, fpm, transparency

All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …

News
ema image

EMA delays trial transparency – again

July 10, 2014
Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency

The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …

News
EMA image

EMA changes ‘on screen’ data policy

June 16, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

News
Esbriet image

InterMune drops EMA lawsuit over data release

June 10, 2014
Research and Development, Sales and Marketing EMA, EU, Esbriet, Goldacre, InterMune, alltrials, lung

InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …

News
Lilly image

Lilly the latest to open up data

June 4, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials

Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …

News
Haslam image

NICE chair: pharma must show how it prices drugs

April 28, 2014
Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars

The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …

News
Glenis Willmott

EU votes for trial transparency

April 3, 2014
Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

News
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature
Novartis image

Novartis extends trial transparency

February 27, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.

News
J&J image

J&J reveals more on transparency policy

February 3, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …

News
GSK image

GSK and Sanofi expand transparency

January 6, 2014
Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency

GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …

News

Latest content

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment

December 6, 2023

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023